| Abbreviation | Meaning |
| CHO | Chinese hamster ovary cell |
| DMEM | Dulbecco’s modified Eagle’s medium |
| ERT | Enzyme replacement therapy |
| ELISA | Enzyme-linked immunosorbent assay |
| FBS | Fetal bovine serum |
| FDA | Food and Drug Administration |
| GBA1 | Glucocerebrosidase, Glucosylceramidase beta 1 |
| GCase | Glucocerebrosidase, Glucosylceramidase beta 1 |
| GD | Gaucher disease |
| GlcCer | Glucosylceramide |
| 293_FT | Human embryonic kidney 293 cells |
| HP | Heterogeneous population |
| HS | High stringency |
| ICGG | International Collaborative Gaucher Group |
| L17 | Lineage 17 |
| LS | Low stringency |
| LV | Lentiviral vector |
| LTR | Long terminal repeat |
| MOI | Multiplicity of infection |
| MTX | Methotrexate |
| 4MU | 4-methylumbiliferone |
| 4MUG | 4-methylumbiliferon-β-D-glucopyranoside |
| qPCR | Real-time quantitative PCR |
| SUS | Unified Health System (Sistema Único de Saúde) |
| TDC | Sodium taurodeoxycholate hydrate |